Bionano Genomics, Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bionano Genomics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Bionano Genomics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$321K, a 147% decline year-over-year.
  • Bionano Genomics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$18.8M, a 869% decline year-over-year.
  • Bionano Genomics, Inc. annual Nonoperating Income (Expense) for 2023 was -$17.2M, a 1843% decline from 2022.
  • Bionano Genomics, Inc. annual Nonoperating Income (Expense) for 2022 was $986K.
  • Bionano Genomics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.05M, a 58.4% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.